Results 191 to 200 of about 1,123,446 (256)

Factors Associated with Response to SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Veterans with Type 2 Diabetes Mellitus. [PDF]

J Clin Med
Arora G, Hashmi S, Kaeli S, Azad S, Batra J, Perugu VD, Davis C, Desouza CV.   +7 more
europepmc   +1 more source

Identification and validation of five novel protein targets for type 2 diabetes mellitus. [PDF]

Sci Rep
Tao M, Ye W, Wu Y, Chang W, Liu F, Zhu Y.   +5 more
europepmc   +1 more source

The Clinically Significant Changes in the Composition and Functional Diversity of the Vaginal Microbiome in Women with Type 2 Diabetes Mellitus. [PDF]

Microorganisms
Kim MJ, Yoo J, Yoo S, Kwon MY, Lee S, Kim M.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Type 2 diabetes mellitus

Nature Reviews Disease Primers, 2015
Type 2 diabetes mellitus (T2DM) is an expanding global health problem, closely linked to the epidemic of obesity. Individuals with T2DM are at high risk for both microvascular complications (including retinopathy, nephropathy and neuropathy) and macrovascular complications (such as cardiovascular comorbidities), owing to hyperglycaemia and individual ...
R. DeFronzo, E. Ferrannini, L. Groop, R. Henry, W. Herman, J. Holst, Frank B. Hu, C. R. Kahn, I. Raz, G. Shulman, D. Simonson, M. Testa, R. Weiss   +12 more
semanticscholar   +9 more sources

Pioglitazone for type 2 diabetes mellitus

Cochrane Database of Systematic Reviews, 2006
Diabetes has long been recognised as a strong, independent risk factor for cardiovascular disease, a problem which accounts for approximately 70% of all mortality in people with diabetes. Prospective studies show that compared to their non-diabetic counterparts, the relative risk of cardiovascular mortality for men with diabetes is two to three and for
Susanne H Ebrahim, Bernd Richter, Karla Bergerhoff, Elizabeth Bandeira-Echtler, Christine Clar   +4 more
openaire   +3 more sources

Microvascular Complications of Type 2 Diabetes Mellitus

Current Vascular Pharmacology, 2020
: Type 2 Diabetes mellitus is a chronic metabolic disease which is associated with increased morbidity and mortality. Long term diabetes is a risk for the development of microvascular complications which affect small blood vessels .
Charles Faselis, Alexandra Katsimardou, K. Imprialos, Pavlos Deligkaris, M. Kallistratos, Kiriakos Dimitriadis   +5 more
semanticscholar   +2 more sources